Gastroesophageal variceal hemorrhage in patients with chronic liver diseases attending university of Gondar Specialized comprehensive hospital in Ethiopia: Institutional based cross-sectional study
- PMID: 37095908
- PMCID: PMC10121785
- DOI: 10.1016/j.heliyon.2023.e15133
Gastroesophageal variceal hemorrhage in patients with chronic liver diseases attending university of Gondar Specialized comprehensive hospital in Ethiopia: Institutional based cross-sectional study
Abstract
Introduction: Rupture and bleeding from Gastroesophageal Varices (GEVs) are major complications among patients with chronic liver disease (CLD) and are associated with a high mortality rate. Hence, identifying factors of Gastroesophageal Variceal Hemorrhage (GEVH) is essential for the management and prevention of this fatal outcome.
Objective: To assess the prevalence of GEVH and its associated factors among patients with CLD in Northwest Ethiopia.
Methods: An institutional based cross-sectional study design was employed on a total of 262 patients. The data was entered into Epi-Data version 3.1, and then exported and analyzed using STATA version 14. The distribution of variables was checked using kolmogorov-smirnov test. Bivariable logistic regression model was fitted to select variables for multivariable analysis. In the final model, adjusted odds ratio with 95% confidence level and P-value less than 0.05 were used to assess degree of association.
Results: The mean age of the study subjects was found to be 37.76 years (SD ± 11.62). The prevalence of GEVH was found to be 52% (95% CI: 49.6-54.2). Patients with grade F2 and F3 varices have 3.41 times (AOR: 3.41, 95% CI: 2.33-4.74) and 3.33 times (AOR: 3.33, 95% CI: 2.55-4.12) higher odds of bleeding, respectively. Patients not taking beta blocker have 2.38 times (AOR: 2.38, 95% CI: 1.82-3.90) increased odds of bleeding. Patients with more than three years of duration of illness have 2 times (AOR: 2.19, 95% CI: 1.39-3.99) increased odds of bleeding. Patients with platelet number less than 50,000/μl have 3.46 times (AOR: 3.46, 95% CI: 2.55-4.17) higher odds of bleeding.
Conclusion: GEVH is found to be high in patients with CLD seen at university of Gondar Hospital. Higher grade of varices, non-use of beta blockers, presence of infection, platelet number and age are associated with higher occurrence of bleeding, pointing the possibility of averting this fatal complication, for most of the identified factors are preventable.
Keywords: Associated factors; Cirrhosis; Ethiopia; Variceal bleeding; Variceal hemorrhage.
© 2023 The Authors.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Denekew Tenaw Anley reports administrative support was provided by 10.13039/501100007861University of Gondar College of Medicine and Health Sciences.
Figures
References
-
- de Dombal F.T., et al. Prognostic factors in upper G.I. bleeding. Endoscopy. 1986;18(Suppl 2):6–10. - PubMed
-
- Smith J., Graham D. Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology. 1982;82(5 Pt 1):968–973. - PubMed
-
- Graham D.Y., Smith J.L. The course of patients after variceal hemorrhage. Gastroenterology. 1981;80(4):800–809. - PubMed
-
- Garcia-Tsao G. Preventing the development of varices in cirrhosis. J. Clin. Gastroenterol. 2007;41(Suppl 3):S300–S304. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
